Phantom study for 90Y post-treatment dosimetry with a long axial field-of-view PET/CT

Purpose: The physical properties of yttrium-90 (90Y) allow for imaging with positron emission tomography/computed tomography (PET/CT). The increased sensitivity of long axial field-of-view (LAFOV) PET/CT scanners possibly allows to overcome the small branching ratio for positron production from 90Y decays and to improve for the post-treatment dosimetry of 90Y of selective internal radiation therapy. Methods: For the challenging case of an image quality body phantom, we compare a full Monte Carlo (MC) dose calculation with the results from the two commercial software packages Simplicit90Y and Hermes. The voxel dosimetry module of Hermes relies on the 90Y images taken with a LAFOV PET/CT, while the MC and Simplicit90Y dose calculations are image independent. Results: The resulting doses from the MC calculation and Simplicit90Y agree well within the error margins. The image-based dose calculation with Hermes, however, consistently underestimates the dose. This is due to the mismatch of the activity distribution in the PET images and the size of the volume of interest. Furthermore, there are likely limitations of Hermes' dose calculation algorithm for 90Y. We found that only for the smallest phantom sphere there is a statistically significant dependence of the Hermes dose on the image reconstruction parameters and scan time. Conclusion: Our study shows that Simplicit90Y's local deposition model can provide a reliable dose estimate. On the other hand, the image based dose calculation requires further benchmarks and verification in order to take full advantage of LAFOV PET/CT systems.

[1]  M. Daube-Witherspoon,et al.  Performance evaluation of the PennPET explorer with expanded axial coverage , 2023, Physics in medicine and biology.

[2]  M. Conti,et al.  Phantom-based evaluation of yttrium-90 datasets using biograph vision quadra , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  R. Froeschl,et al.  New Capabilities of the FLUKA Multi-Purpose Code , 2022, Frontiers in Physics.

[4]  B. Spencer,et al.  Radioembolization Dosimetry with Total-Body 90Y PET , 2021, The Journal of Nuclear Medicine.

[5]  S. Walrand,et al.  Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters , 2021, Frontiers in Oncology.

[6]  A. Afshar-Oromieh,et al.  Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard , 2021, The Journal of Nuclear Medicine.

[7]  A. Haug,et al.  Comparing calculated and experimental activity and dose values obtained from image-based quantification of 90Y SPECT/CT Data. , 2021, Zeitschrift fur medizinische Physik.

[8]  A. Afshar-Oromieh,et al.  Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  D. Sze,et al.  International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  S. Ziegler,et al.  3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates. , 2020, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[11]  R. Hustinx,et al.  EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy , 2020, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  Yun Dong,et al.  Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View , 2020, The Journal of Nuclear Medicine.

[13]  P. Dryák,et al.  Measurement of the branching ratio related to the internal pair production of Y-90. , 2020, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[14]  S. Padia,et al.  Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET. , 2019, Seminars in nuclear medicine.

[15]  Pengcheng Hu,et al.  First Human Imaging Studies with the EXPLORER Total-Body PET Scanner* , 2019, The Journal of Nuclear Medicine.

[16]  W. Moses,et al.  Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care , 2018, The Journal of Nuclear Medicine.

[17]  Rachida Lebtahi,et al.  Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. , 2017, The Lancet. Oncology.

[18]  Antti O Sohlberg,et al.  Dosimetry software Hermes Internal Radiation Dosimetry: from quantitative image reconstruction to voxel-level absorbed dose distribution , 2017, Nuclear medicine communications.

[19]  Manuel Sánchez-García,et al.  Absorbed-dose calculation for treatment of liver neoplasms with 90Y-microspheres , 2016, Clinical and Translational Imaging.

[20]  A. Sohlberg,et al.  Quantitative accuracy of 177Lu SPECT reconstruction using different compensation methods: phantom and patient studies , 2016, EJNMMI Research.

[21]  A. Sohlberg,et al.  Fast voxel-level dosimetry for 177Lu labelled peptide treatments , 2015, Physics in medicine and biology.

[22]  P. W. Chin,et al.  Overview of the FLUKA code , 2014, ICS 2014.

[23]  S. M. Seltzer,et al.  Key Data for Ionizing-Radiation Dosimetry: Measurement Standards and Applications , 2014, Journal of the ICRU.

[24]  Marnix G. E. H. Lam,et al.  Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization , 2013, PloS one.

[25]  Wenzheng Feng,et al.  Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90 Y microsphere brachytherapy in the treatment of hepatic malignancies. , 2011, Medical physics.

[26]  F. Forrer,et al.  EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  Renaud Lhommel,et al.  Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  D. Kocher Nuclear Data Sheets for A = 90* , 1975 .

[29]  Wenzheng Feng,et al.  Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. , 2011, Medical physics.

[30]  Vlachoudis FLAIR: A POWERFUL BUT USER FRIENDLY GRAPHICAL INTERFACE FOR FLUKA , 2009 .